medigraphic.com
ISSN 2448-8909 (Impreso)

2020, Número 1

<< Anterior Siguiente >>

Med Crit 2020; 34 (1)


Guía COVID-19 para la atención del paciente crítico con infección por SARS-CoV-2 Colegio Mexicano de Medicina Crítica

Grupo de Trabajo Mexicano COVID-19/COMMEC

Idioma: Español
Referencias bibliográficas: 94
Paginas: 7-42
Archivo PDF: 842.37 Kb.


FRAGMENTO

El Colegio Mexicano de Medicina Crítica (COMMEC), preocupado por la llegada a nuestro país de COVID-19 y por su consiguiente expansión, ha reunido a los expertos del Colegio en diversas áreas de interés, las cuales pueden ser de utilidad para los médicos intensivistas y no intensivistas para que puedan recibir y manejar a pacientes graves con esta enfermedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19) [sitio web]. Treasure Island, Florida: Stat Pearls Publishing; 2020 [visitado el 8 de marzo de 2020]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK554776/.

  2. Organización Mundial de la Salud. Manual de bioseguridad en el laboratorio. 3a. edición. Ginebra: Organización Mundial de la Salud;2015.

  3. Secretaría de Salud. Lineamiento de reconversión hospitalaria [sitio web]. México: Gobierno de México, Secretaría de Salud;2020 [visitado: 5 abril de 2020]. Disponible en: https://coronavirus.gob.mx/wp-content/uploads/2020/04/Documentos-Lineamientos-Reconversion-Hospitalaria.pdf.

  4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10222):391-93.

  5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

  6. Secretaría de Salud, Dirección General de Epidemiología. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de COVID-19 [sitio web]. México: Gobierno de México, Secretaría de Salud; 2020. Disponible en: https://www.gob.mx/salud/documentos/nuevo-coronavirus.

  7. Secretaría de Salud. Manual de recomendaciones intervención de pacientes con Infección Respiratoria Aguda por COVID-19. Hospital General Xoco. México: Gobierno de México, Secretaría de Salud; 2020.

  8. Secretaría de Salud. Lineamientos de Conversión por Contingencia por Pandemia de COVID-19. Hospital General Xoco. México: Gobierno de México, Secretaría de Salud; 2020.

  9. Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.

  10. Wei-jie G, Zheng-yi N, Yu H, Wen-hua L, Chun-quan O, Jian-xing H, Lei L, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020:1-13.

  11. España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, et al. Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia. Am J Respir Crit Care Med. 2006;174:1249-1256.

  12. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307:2526-2533.

  13. Li T. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0). Emerg Microbes Infec. 2020;9(1):582-585. doi:10.1080/22221751.2020.1735265.

  14. Alhazzani W, Møller M, Arabi Y, Loeb M, Gong M, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020. doi: 10.1007/s00134-020-06022-5. [Epub ahead of print].

  15. Bai HX, Hsieh B, Xiong Z, Halsey K, Whae-Choi, Linh Tran TM, Pan I, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020. https://doi.org/10.1148/radiol.2020200823.

  16. Wong HYF, Lam HYS, Fong AH, Leung ST, Chin TW, Lo CSY, Lui MM, et al. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients. Radiology. 2020. doi: 10.1148/radiol.2020201160. [Epub ahead of print].

  17. 1 National Institute for Health and Care Excellence. COVID-19 rapid guideline: critical care in adults [sitio web]. UK: NICE; 2020 [visitado el 24 de abril de 2020]. Disponible en: https://www.nice.org.uk/guidance/ng159.

  18. Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999;27(3):633-638.

  19. Sanchíz OR, Estella García A, Cruz Delgado M, Saralegui Reta I, Cabré Pericas L, Zapata Fenor L. Recomendaciones Éticas para la toma de decisiones en la situación excepcional de crisis por Pandemia COVID-19 en las Unidades de Cuidados Intensivos [sitio web]. España: Sociedad Española de Medicina Intensiva, Critica y Unidades Coronarias; 2020 [actualizado a marzo de 2020]. Disponible en: https://semicyuc.org/wp-content/uploads/2020/03/Ética_SEMICYUC-COVID-19.pdf.

  20. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection. 2020;104(3):246-251. doi:10.1016/j.jhin.2020.01.022.

  21. World Health Organization. Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance 19 March 2020 [sitio web]. World Health Organization; 2020 [Updated 27 February 2020]. Disponible en: https://apps.who.int/iris/handle/10665/331215.

  22. Cheung JCH, Tin Ho L, Cheng JV, Kwan Cham EY, Lam KN. Staff safety during emergency airway management for COVID-19 in Hong Kong. Lancet Respir Med. 2020. Disponible en: https://doi.org/10.1016/S2213-2600(20)30084-9.

  23. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19) [sitio web]. Treasure Island, Florida: Stat Pearls Publishing; 2020 [8 March 2020]. Disponible

  24. en: https://www.ncbi.nlm.nih.gov/books/NBK554776/.

  25. Xia JG, Zhao JP, Cheng ZS, Hu Y, Duan J, Zhan QY. Non-invasive respiratory support for patients with novel coronavirus pneumonia. Chin Med J (Engl). 2020. doi: 10.1097/CM9.0000000000000761. [Epub ahead of print].

  26. Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019;53: pii: 1802339. doi: 10.1183/13993003.02339-2018.

  27. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review. PLoS One. 2012;7(4):e35797. doi: 10.1371/journal.pone.0035797.

  28. Alraddadi BM, Qushmaq I, Al‐Hameed FM, Mandourah Y, Almekhlafi GA, Jose J, The Saudi Critical Care Trials Group, et al. Non invasive ventilation in critically patients with the Middle East respiratory syndrome. Influenza Other Respir Viruses. 2019;13(4):382-390.

  29. Gamage B, Moore D, Copes R, Yassi A, Bryce E. Protecting healthcare workers from SARS and other respiratory pathogens: A review of the infection control literature. Am J Infect Control. 2005;33(2):114-121.

  30. Khoo SM, Tan LK, Said N, Lim TK. Metered-dose inhaler with spacer instead of nebulizer during the outbreak of severe acute respiratory syndrome in Singapore. Respir Care. 2009;54(7):855-60.

  31. Alhazzani W, Møller M, Arabi Y, Loeb M, Gong M, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020. doi: 10.1007/s00134-020-06022-5. [Epub ahead of print].

  32. Alhazzani W, Møller M, Arabi Y, Loeb M, Gong M, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020. doi: 10.1007/s00134-020-06022-5. [Epub ahead of print].

  33. Higgs A, McGrath BA, Goddard C, Rangasami J, Suntharalingam G, Gale R, et al. Guidelines for the management of tracheal intubation in critically ill adults. Br J Anaesth. 2018;120:323-352.

  34. Peng PWH, Ho PL, Hota SS. Outbreak of a new coronavirus: what anaesthetists should know. Br J Anaesth. 2020;124(5):497-501. doi:S0007-0912(20)30098-2.

  35. Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth. 2020;67(5):568-576. doi.org/10.1007/s12630-020-01591-x.

  36. Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, Huang J, Chen X. Anesthetic Management of Patients With Suspected or Confirmed 2019 Novel Coronavirus Infection During Emergency Procedures. J Cardiothorac Vasc Anesth. 2020;34:1125-1131.

  37. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020;4:145-151.

  38. Cook TM. Strategies for the prevention of airway complications. A narrative review. Anaesthesia. 2018;73:93-111.

  39. Janz DR, Semler MW, Joffe AM, Casey JD, Lentz RJ, de Boisblanc BP, et al. A Multicenter Randomized Trial of a Checklist for Endotracheal Intubation of Critically Ill Adults. Chest. 2018;816-824.

  40. Ojeda J, Paret N, Ojeda L. Consideraciones sobre anestesia en cirugía torácica. Medisur. 2013;11-5.

  41. Zuo MZ, Huang YG, Ma WH, Xue ZG, Zhang JQ, Gong YH, et al. Expert Recommendations for Tracheal Intubation in Critically ill Patients with Novel Coronavirus Disease 2019. Chin Med Sci J. 2020 doi:10.24920/003724.

  42. Quintard H, l’Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, et al. Experts’ guidelines of intubation and extubation of the ICU patient of French Society of Anaesthesia and Intensive Care Medicine (SFAR) and French-speaking Intensive Care Society (SRLF). Ann Intensive Care. 2019;13: doi:10.1186/s13613-019-0483-1.

  43. Wahidi MM, Lamb C, Murgu S, Musani A, Shojaee S, Sachdeva A, Maldonado F, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection. J Bronchology Interv Pulmonol. 2020: doi: 10.1097/LBR.0000000000000681. [Epub ahead of print].

  44. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10222):391-93.

  45. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

  46. Secretaría de Salud, Dirección General de Epidemiología. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de COVID-19 [sitio web]. México: Gobierno de México, Secretaría de Salud; 2020. Disponible en: https://coronavirus. https://www.gob.mx/salud/documentos/nuevo-coronavirus.

  47. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenge. Int J Antimicrob Agents. 2020;(3):105924. doi: 10.1016/j.ijantimicag.2020.105924.

  48. Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020;55(3):105923. doi: 10.1016/j.ijantimicag.2020.105923.

  49. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-271.

  50. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J of Cril Care. 2020: doi: 10.1016/j.jcrc.2020.03.005. [Epub ahead of print].

  51. McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis, and prevention [sitio web]. Uptodate; 2020 [Consultado en abril de 2020]. Disponible en https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19.

  52. Rolain JM, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. International Journal of Antimicrobial Agents. 2007; 30(4):297-308.

  53. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69.

  54. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;20:105949.

  55. Jun C, Danping L, Li L, Ping L, Qingnian X, Lu X, et al. A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). J Zhejiang Univ (Med Sci). 2020;49(1): 0-0. doi: 10.3785/j.issn.1008-9292.2020.03.03.

  56. Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. MedRxiv. 2020. doi: https://doi.org/10.1101/2020.03.22.20040758.

  57. Simpson TF, Kovacs RJ, Stecker EC. Ventricular arrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19. America College of Cardiology. 2020.

  58. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19. N Engl J Med. 2020: DOI: 10.1056/NEJMoa2001282.

  59. Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9(396):pii: eaal3653. doi: 10.1126/scitranslmed.aal3653.

  60. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-1034.

  61. University Hospital Ghent, Belgium Health Care Knowledge Centre. Treatment of COVID-19 Patients With Anti-interleukin Drugs (COV-AID) [sitio web]. USA: National Library of Medicine ClinicalTrials.gov; 2020 [updated 24 April 2020]. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04330638?term=IL-6&cond=COVID-19&draw=2&rank=1.

  62. Copetti R. Is lung ultrasound the stethoscope of the new millennium? Definitely yes! Acta Med Acad. 2016;45:80-81.

  63. WHO. Medical devices. Personal protective equipment [sitio web]. World Health Organization; 2020 [Consultado: 6 de marzo de 2020]. Disponible en https://www.who.int/medical_ devices/meddev_ppe/en/.

  64. Lichtenstein DA, Malbrain MLNG. Lung ultrasound in the critically ill (LUCI): a translational discipline. Anaesthesiol Intensive Ther. 2017;49:430-36.

  65. Mayo PH, Copetti R. Thoracic ultrasonography: a narrative review. Intensive Care Med. 2019; 45:1200-1211.

  66. Peng QY, Wang XT, Zhang LN, Chinese Critical Care Ultrasound Study Group (CCUSG). Chinese Critical Care Ultrasound Study Group (CCUSG). Intensive Care Med. 2020: doi: 10.1007/s00134-020-05996-6. [Epub ahead of print].

  67. Buonsenso D, Pata D, Chiaretti A. COVID-19 outbreak: less stethoscope, more ultrasound. The Lancet. Resp Med. 2020: doi: https://doi.org/10.1016/S2213-2600(20)30120-X.

  68. Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, Perlini S, et al. Is there a role for lung ultrasound during the COVID-19 pandemic? J Ultrasound Med. 2020. doi: 10.1002/jum.15284. [Epub ahead of print].

  69. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;1-3. doi: 10.1007/s00134-020-05991-x.

  70. Ospina-Tascón GA, Bautista DF, Madriñán HJ, Valencia JD, Bermúdez WF, Quiñones E, Calderón-Tapia LE, et al. Microcirculatory dysfunction and dead-space ventilation in early ARDS: a hypothesis-generating observational study. Ann Intensive Care. 2020;10(1):35.

  71. Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17(1):109.

  72. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-1034.

  73. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital. Intensive Care Med. 2020;1-3. https://doi.org/10.1007/s00134-020-05993-9.

  74. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020. doi: 10.1001/jamacardio.2020.0950. [Epub ahead of print].

  75. Schunkert H, Erbel R. Evidence-based primary prevention: Where do we stand in 2020? Herz. 2020;45(1):1-2.

  76. Sondergaard S. Pavane for a pulse pressure variation defunct. Crit Care. 2013;17(6):327.

  77. Vieillard-Baron A, Chergui K, Augarde R, et al. Cyclic changes in arterial pulse during respiratory support revisited by Doppler echocardiography. Am J Respir Crit Care Med. 2003;168(6):671-676.

  78. Grissom CK, Hirshberg EL, Dickerson JB, Brown SM, Lanspa MJ, Liu KD, Schoenfeld D, et al. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome. Crit Care Med. 2015;43(2):288-295.

  79. Wilson JG, Calfee CS. ARDS Subphenotypes: Understanding a Heterogeneous Syndrome. Crit Care. 2020;24(1):102.

  80. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331-338.

  81. Tourneux P, Rakza T, Bouissou A, Krim G, Storme L. Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension. J Pediatr. 2008;153(3):345-349.

  82. Mizota T, Fujiwara K, Hamada M, Matsukawa S, Segawa H. Effect of arginine vasopressin on systemic and pulmonary arterial pressure in a patient with pulmonary hypertension secondary to pulmonary emphysema: a case report. JA Clin Rep. 2017;3(1):1.

  83. Mekontso Dessap A, Boissier F, Charron C, Bégot E, Repessé X, Legras A, et al. Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. Intensive Care Med. 2016;42:862-70.

  84. Repessé X, Vieillard-Baron A. Right heart function during acute respiratory distress syndrome. Ann Transl Med. 2017;5(14):295.

  85. Ferraris A, Bouisse C, Mottard N, et al. Mottling score and skin temperature in septic shock:Relation and impact on prognosis in ICU. PLoS One. 2018;13(8):e0202329.

  86. Pickard A, Karlen W, Ansermino JM. Capillary refill time: is it still a useful clinical sign? Anesth Analg. 2011;113(1):120-123.

  87. Berridge JC. Influence of cardiac output on the correlation between mixed venous and central venous oxygen saturation. Br J Anaesth. 1992;69(4):409-410.

  88. Mallat J, Lemyze M, Tronchon L, Vallet B, Thevenin D. Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock. World J Crit Care Med. 2016;5(1):47-56.

  89. The ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526-33.

  90. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E et. al. Prone Positioning in Severe Acute Respiratory Distress Syndrome. N Engl J Med 2013;368:2159-2168.

  91. Cavalcanti AB, Suzumura EA, Laranjeira LN, Paisani DM, Damiani LP, Guimarães HP, Romano ER, et al. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome A Randomized Clinical Trial. JAMA. 2017;318(14):1335-1345.

  92. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious disease, The Lancet Respir Med. 2020. doi: https://doi.org/10.1016/S2213-2600(20)30121-1.

  93. MacLaren G, Fisher D, Brodie D. Preparing for the Most Critically III Patients With COVID-19 The Potential Role of Extracorporeal Membrane Oxygenation. JAMA. 2020. doi: 10.1001/jama.2020.2342. [Epub ahead of print].

  94. Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA. 2019;322(6):557-568.




2020     |     www.medigraphic.com